TAM
Tocqueville Asset Management’s Arcturus Therapeutics ARCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $373K | Buy |
28,700
+5,300
| +23% | +$69K | 0.01% | 448 |
|
|
2025
Q1 | $248K | Buy |
23,400
+1,000
| +4% | +$10.6K | ﹤0.01% | 478 |
|
|
2024
Q4 | $380K | Buy |
22,400
+6,700
| +43% | +$114K | 0.01% | 451 |
|
|
2024
Q3 | $364K | Buy |
15,700
+1,700
| +12% | +$39.5K | 0.01% | 441 |
|
|
2024
Q2 | $341K | Sell |
14,000
-500
| -3% | -$12.2K | 0.01% | 444 |
|
|
2024
Q1 | $490K | Sell |
14,500
-1,400
| -9% | -$47.3K | 0.01% | 412 |
|
|
2023
Q4 | $501K | Buy |
15,900
+600
| +4% | +$18.9K | 0.01% | 401 |
|
|
2023
Q3 | $391K | Buy |
15,300
+2,200
| +17% | +$56.2K | 0.01% | 420 |
|
|
2023
Q2 | $376K | Sell |
13,100
-5,100
| -28% | -$146K | 0.01% | 435 |
|
|
2023
Q1 | $436K | Buy |
+18,200
| New | +$436K | 0.01% | 425 |
|
|
2020
Q2 | – | Sell |
-10,450
| Closed | -$142K | – | 653 |
|
|
2020
Q1 | $142K | Buy |
+10,450
| New | +$142K | ﹤0.01% | 610 |
|